Fig. 2From: Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPARγ/PTEN/mTOR signaling pathwayThe proliferation of A549 cells treated with bexarotene, bexarotene + slc10a2-shRNA, bexarotene + slc10a2-overexpression respectively. A549 cells without treatment as control. All experiments were repeated 3 timesBack to article page